Literature DB >> 20800895

Complement regulates TLR4-mediated inflammatory responses during intestinal ischemia reperfusion.

Michael R Pope1, Sara M Hoffman, Stephen Tomlinson, Sherry D Fleming.   

Abstract

Innate immune responses including TLR4 and complement activation are required for mesenteric ischemia/reperfusion (IR)-induced tissue damage. We examined the regulation of TLR4 and complement activation in a mouse model of intestinal IR. Intestinal IR-induced C3 deposition in a TLR4 dependent manner. In addition, in wild-type but not TLR4 deficient mice, IR significantly increased C3 and Factor B (FB) mRNA expression within the intestine. To further examine the role of TLR4 and complement, we administered the complement inhibitor, CR2-Crry, to target local complement activation in wild-type C57Bl/10, and TLR4 deficient B10/ScN mice. TLR4 deficient mice sustained less damage and inflammation after IR than wild-type mice, but administration of CR2-Crry did not further reduce tissue damage. In contrast, CR2-Crry treatment of wild-type mice was accompanied by a reduction in complement activation and in C3 and FB transcription in response to IR. CR2-Crry also significantly decreased intestinal IL-6 and IL-12p40 production in both the wild-type and TLR4 deficient mice. These data indicate that TLR4 regulates extrahepatic complement production while complement regulates TLR4-mediated cytokine production during intestinal IR.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20800895      PMCID: PMC2993765          DOI: 10.1016/j.molimm.2010.07.004

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  44 in total

Review 1.  Complement activation following oxidative stress.

Authors:  C D Collard; R Lekowski; J E Jordan; A Agah; G L Stahl
Journal:  Mol Immunol       Date:  1999 Sep-Oct       Impact factor: 4.407

2.  Decay-accelerating factor (DAF/CD55) is a functional active element of the LPS receptor complex.

Authors:  H Heine; A J Ulmer; V T El-Samalouti; A Lentschat; L Hamann
Journal:  J Endotoxin Res       Date:  2001

Review 3.  Innate recognition of bacteria: engagement of multiple receptors.

Authors:  Martha Triantafilou; Klaus Brandenburg; Thomas Gutsmann; Ulrich Seydel; Kathy Triantafilou
Journal:  Crit Rev Immunol       Date:  2002       Impact factor: 2.214

Review 4.  Recognition of pathogen-associated molecular patterns by TLR family.

Authors:  Shizuo Akira; Hiroaki Hemmi
Journal:  Immunol Lett       Date:  2003-01-22       Impact factor: 3.685

5.  C5a causes limited, polymorphonuclear cell-independent, mesenteric ischemia/reperfusion-induced injury.

Authors:  Sherry D Fleming; Dimitrios Mastellos; Georg Karpel-Massler; Terez Shea-Donohue; John D Lambris; George C Tsokos
Journal:  Clin Immunol       Date:  2003-09       Impact factor: 3.969

Review 6.  Role of the gut lymphatic system in multiple organ failure.

Authors:  E A Deitch
Journal:  Curr Opin Crit Care       Date:  2001-04       Impact factor: 3.687

7.  Complement inhibitor, complement receptor 1-related gene/protein y-Ig attenuates intestinal damage after the onset of mesenteric ischemia/reperfusion injury in mice.

Authors:  S Rehrig; S D Fleming; J Anderson; J M Guthridge; J Rakstang; C E McQueen; V M Holers; G C Tsokos; T Shea-Donohue
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

8.  Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma.

Authors:  C L Karp; A Grupe; E Schadt; S L Ewart; M Keane-Moore; P J Cuomo; J Köhl; L Wahl; D Kuperman; S Germer; D Aud; G Peltz; M Wills-Karp
Journal:  Nat Immunol       Date:  2000-09       Impact factor: 25.606

9.  Prostaglandin E(2) is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer.

Authors:  P Kaliński; P L Vieira; J H Schuitemaker; E C de Jong; M L Kapsenberg
Journal:  Blood       Date:  2001-06-01       Impact factor: 22.113

10.  Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire.

Authors:  Sherry D Fleming; Terez Shea-Donohue; Joel M Guthridge; Liudmila Kulik; Thomas J Waldschmidt; Matthew G Gipson; George C Tsokos; V Michael Holers
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

View more
  24 in total

1.  MicroRNA-351-5p aggravates intestinal ischaemia/reperfusion injury through the targeting of MAPK13 and Sirtuin-6.

Authors:  Yupeng Hu; Xufeng Tao; Xu Han; Lina Xu; Lianhong Yin; Huijun Sun; Yan Qi; Youwei Xu; Jinyong Peng
Journal:  Br J Pharmacol       Date:  2018-07-26       Impact factor: 8.739

2.  Mesenchymal stem cells cannot affect mRNA expression of toll-like receptors in different tissues during sepsis.

Authors:  Leonardo Pedrazza; Talita Carneiro Brandão Pereira; Ana Lucia Abujamra; Fernanda Bordignon Nunes; Maurício Reis Bogo; Jarbas Rodrigues de Oliveira
Journal:  Inflamm Res       Date:  2017-04-08       Impact factor: 4.575

3.  Helicobacter infection alters MyD88 and Trif signalling in response to intestinal ischaemia-reperfusion.

Authors:  Sara M Hoffman; Hua Wang; Michael R Pope; Sherry D Fleming
Journal:  Exp Physiol       Date:  2010-11-05       Impact factor: 2.969

4.  Radiotherapy: killing with complement.

Authors:  Jean F Regal; Kenneth J Dornfeld; Sherry D Fleming
Journal:  Ann Transl Med       Date:  2016-03

5.  TLR2 modulates antibodies required for intestinal ischemia/reperfusion-induced damage and inflammation.

Authors:  Michael R Pope; Sherry D Fleming
Journal:  J Immunol       Date:  2014-12-24       Impact factor: 5.422

6.  Small β2-glycoprotein I peptides protect from intestinal ischemia reperfusion injury.

Authors:  Michael R Pope; Urska Bukovnik; John M Tomich; Sherry D Fleming
Journal:  J Immunol       Date:  2012-10-03       Impact factor: 5.422

Review 7.  Membrane lipid interactions in intestinal ischemia/reperfusion-induced Injury.

Authors:  Emily Archer Slone; Sherry D Fleming
Journal:  Clin Immunol       Date:  2014-05-09       Impact factor: 3.969

8.  Delineating the relationships among the formation of reactive oxygen species, cell membrane instability and innate autoimmunity in intestinal reperfusion injury.

Authors:  Haekyung Lee; Eun Hee Ko; Mark Lai; Na Wei; Javi Balroop; Zerin Kashem; Ming Zhang
Journal:  Mol Immunol       Date:  2013-12-22       Impact factor: 4.407

9.  TLR9 is dispensable for intestinal ischemia/reperfusion-induced tissue damage.

Authors:  Emily Archer Slone; Michael R Pope; Mary Roth; Ruth Welti; Sherry D Fleming
Journal:  Am J Clin Exp Immunol       Date:  2012

10.  The receptor for complement component C3a mediates protection from intestinal ischemia-reperfusion injuries by inhibiting neutrophil mobilization.

Authors:  Mike C L Wu; Faith H Brennan; Jason P L Lynch; Susanna Mantovani; Simon Phipps; Rick A Wetsel; Marc J Ruitenberg; Stephen M Taylor; Trent M Woodruff
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.